Brian Skorney

Stock Analyst at Baird

(0.32)
# 2017
Out of 5,240 analysts
136
Total ratings
42.86%
Success rate
6.35%
Average return
41 Stocks
Name Action Price Target Current % Upside Ratings Updated
Dyne Therapeutics
Initiates Coverage On: Outperform
46
15.14 203.83% 1 Dec 13, 2024
Benitec Biopharma
Initiates Coverage On: Outperform
30
10.32 190.7% 1 Dec 13, 2024
Soleno Therapeutics
Reiterates: Outperform
72 72
43.67 64.87% 2 Dec 2, 2024
Applied Therapeutics
Maintains: Outperform
14 5
0.69 624.64% 4 Nov 29, 2024
Enanta Pharma
Maintains: Outperform
26 20
4.91 307.33% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
294 300
145.32 106.44% 15 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
44 50
44.7 11.86% 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 193
120.97 59.54% 7 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 95
91.91 3.36% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
7.55 231.13% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 10
4.46 124.22% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
215 215
270.74 -20.59% 3 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 60
36.74 63.31% 2 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 180
140.08 28.5% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
5.87 377% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 62
37.06 67.3% 4 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 2
0.54 270.37% 4 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 39
7.36 429.89% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
280 30
n/a n/a 2 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
40.3 56.33% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 173
n/a n/a 8 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 150
n/a n/a 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
800 760
698.75 8.77% 12 Jun 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 18
n/a n/a 5 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 325
419.49 -22.52% 14 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 27
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 55
n/a n/a 4 Oct 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
23.74 -57.88% 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
270
2.86 9340.56% 1 May 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 6
5.23 14.72% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 100
n/a n/a 2 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101
n/a n/a 3 Nov 1, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 300
3.21 9245.79% 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 2 Jan 30, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 14, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 8, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2016